S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

$28.02
+0.42 (+1.52%)
(As of 03/27/2024 ET)
Today's Range
$27.77
$28.02
50-Day Range
$26.96
$28.34
52-Week Range
$23.85
$28.41
Volume
11,683 shs
Average Volume
7,746 shs
Market Capitalization
$21.02 million
Assets Under Management
$20.70 million
Dividend Yield
1.71%
Net Expense Ratio
0.60%
FTXH stock logo

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

FTXH Stock Price History

FTXH ETF News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Solid Q4 Earnings Fail to Impress Pharma ETFs
See More Headlines
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
51

Fund Statistics

Assets Under Management
$20.70 million
Average Daily Volume
$5,948.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Old Mission

Options

Optionable
N/A
Short Interest
1,000 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$500.00
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.40%0.54%0.32%0.58%
Total Expense0.60%0.72%0.70%0.57%0.70%
Fee Waiver0.00%-0.53%-0.54%-0.20%-0.56%
Net Expense0.60%0.61%0.60%0.54%0.58%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & Exposure

FTXH Sector Exposure

FTXH Industry Exposure


FTXH ETF - Frequently Asked Questions

How have FTXH shares performed in 2024?

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 at the beginning of the year. Since then, FTXH shares have increased by 5.3% and is now trading at $28.02.
View the best growth stocks for 2024 here
.

How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF announced a dividend on Wednesday, March 20th. Shareholders of record on Friday, March 22nd will be paid a dividend of $0.0676 per share on Thursday, March 28th. The ex-dividend date is Thursday, March 21st.
Read our dividend analysis for FTXH
.

What does FTXH invest in?

First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $20.70 million assets under management.

What stocks does First Trust Nasdaq Pharmaceuticals ETF hold?
What is the management fee for First Trust Nasdaq Pharmaceuticals ETF?

First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%.

What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC), BioCorRx (BICX), BlackRock Municipal Income Trust (BFK), AmeriGas Partners (APU) and Aphria (APHA).

Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders?

First Trust Nasdaq Pharmaceuticals ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include International Assets Investment Management LLC (10.26%), International Assets Investment Management LLC (10.26%), Goldman Sachs Group Inc. (8.29%), Goldman Sachs Group Inc. (8.29%), Steward Partners Investment Advisory LLC (7.33%) and Outlook Wealth Advisors LLC (1.15%).

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FTXH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners